DUBLIN, Jan. 13, 2021 /PRNewswire/ -- The "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions: Industry Trends and Global Forecasts (3rd Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the 3D cell culture market. Based on multiple parameters, such as business segment, price of 3D cell culture products, and likely adoption of the 3D cell culture products, we have provided informed estimates on the likely evolution of the 3D cell culture systems market in the mid to long term.
An insightful assessment of the current market landscape of companies offering various 3D cell culture systems, along with information on a number of relevant parameters, such as year of establishment, size of employee base, geographical presence, 3D cell culture format (scaffold based products, scaffold free products and 3D bioreactors), and type of product (hydrogels / ECMs, micropatterned surfaces, solid scaffolds, microcarriers, attachment resistant surfaces, suspension systems and microfluidic systems). In addition, the chapter provides information related to the companies providing 3D culture related services, and associated reagents / consumables.
A detailed assessment of the overall landscape of scaffold based products, along with information on a number of relevant parameters, such as status of development (under development, developed not commercialized, and commercialized), type of product (hydrogels / ECMs, micropatterned surfaces, solid scaffolds, and microcarriers), source of 3D cultured cells (natural and synthetic), method used for fabrication (human based, animal based, plant based, and polymer based), and material used for fabrication. In addition, it presents details of the companies developing scaffold based products, highlighting year of establishment, size of employee base, and geographical presence.
A detailed assessment of the overall landscape of scaffold free products, along with information on a number of relevant parameters, such as status of development (under development, developed and not commercialized, and commercialized), type of product (attachment resistant surfaces, suspension systems and microfluidic systems), source of 3D cultured cells (natural and synthetic), method used for fabrication (human based, animal based, plant based and polymer based), and material used for fabrication. In addition, it presents details of the companies developing scaffold free products, highlighting their year of establishment, size of employee base, and geographical presence.
A detailed assessment of the overall landscape of 3D bioreactors, along with information on a number of relevant parameters, such as type of 3D bioreactor (single-use, perfusion, fed-batch, and fixed-bed), and typical working volume. In addition, it presents details of the companies developing 3D bioreactors, highlighting year of establishment, size of employee base, and geographical presence.
An insightful analysis, highlighting the applications (cancer research, drug discovery and toxicology, stem cell research, tissue engineering and regenerative medicine) for which various 3D cell culture products are being developed / used.
An in-depth analysis of over 8,400 patents that have been filed / granted for 3D cell culture products, between 2015 and 2020, highlighting key trends associated with these patents, across type of patent, publication year, issuing authorities involved, CPC symbols, emerging focus areas, leading patent assignees (in terms of number of patents filed / granted), patent characteristics and geography. It also includes a detailed patent valuation analysis.
An in-depth discussion on the classification of 3D cell culture systems, categorized as scaffold based systems (hydrogels / ECMs, solid scaffolds, micropatterned surfaces and microcarriers), scaffold free systems (attachment resistant surfaces, suspension systems and microfluidic systems) and 3D bioreactors.
An elaborate discussion on the methods used for fabrication of 3D matrices and scaffolds, highlighting the materials used, the process of fabrication, merits and demerits, and the applications of different fabrication methods.
Key Questions Answered
Who are the leading industry players engaged in the development of 3D cell culture products?
What are the most popular 3D cell culture products?
What are the different applications for which 3D cell culture products are currently being developed?
What are the key factors that are likely to influence the evolution of this market?
What is the trend of capital investments in the 3D cell culture systems market?
Which partnership models are commonly adopted by stakeholders in this industry?
How is the COVID-19 pandemic likely to impact the 3D cell culture systems market?
How is the current and future opportunity likely to be distributed across key market segments?
What are the anticipated future trends related to 3D cell culture systems market?
3D Biotechnology Solutions
Åbo Akademi University
Advanced Regenerative Manufacturing Institute (ARMI)
Agency for Science, Technology and Research (A*STAR)
American Laboratory Products
ALS Investment Fund
Angels in MedCity
Aquitaine Science Transfert
Arizona State University
Braveheart Investment Group
BRTI Life Sciences
University of Cambridge
Cedars-Sinai Medical Center
Center for the Advancement of Science in Space
Charles River Laboratories
China Regenerative Medicine International
CN Bio Innovations
Comune di Milano
Corning Life Sciences
Commonwealth Serum Laboratories
United States Department of Defense
Development Bank of Wales
Government of the Netherlands
Executive Agency for Small and Medium-sized Enterprises (EASME)
European Life Sciences Growth Fund (ELSGF)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Fennik Life Sciences
Foundation for Technological Innovation
FUJIFILM Wako Pure Chemical
Genome Institute of Singapore
Georgia Research Alliance
Global Cell Solutions
Government of China
Great Stuff Ventures
Human Models for Analysis of Pathways (HMAPs) Center
HP Wild Holding
Hubrecht Organoid Technology
IMSS-Gulf Bio Analytical
Innovation Fund Denmark
Inova Health System
Irdi Soridec Gestion
Japan Vilene Company
Jellagen Marine Biotechnologies
Johns Hopkins University
Kim & Friends
Koninklijke Nederlandse Akademie Van Wetenschappen
LAMBDA Laboratory Instruments
Lawrence J. Ellison Institute for Transformative Medicine
LBA Healthcare Management
Laboratory for Integrated Micro Mechatronic Systems
Lineage Cell Therapeutics
London School of Hygiene & Tropical Medicine
University of Mannheim
Maryland Momentum Fund
Massachusetts Institute of Technology
MatTek Life Sciences
Menicon Life Science
Michael J. Fox Foundation
Michigan Technological University
Minerva Business Angel Network
Maryland Stem Cell Research Fund (MSCRF)
National Aeronautics and Space Administration
National Center for Advancing Translational Sciences
National Institute of Health
National Institute on Aging
National Institutes for Food and Drug Control
National Science Foundation
National University Hospital
National University of Singapore
National Centre for the Replacement, Refinement and Reduction of Animals in Research
New Orleans BioFund
Newable Private Investing
Nord France Amorquage
Invest Northern Ireland
Northwick Park Institute for Medical Research
Novartis Venture Fund
NYU Winthrop Hospital
OMNI Life Science
Oregon Health & Science University
Peak Capital Advisors
Quintech Life Sciences
PT Rajawali Medika Mandiri
Research Without Animal Experiment
Roswell Park Comprehensive Cancer Center
Scinus Cell Expansion
Scottish Investment Bank
Shanghai Cienle Medical Technology
Shanghai Institute of Materia Medica
Shanghai Institute of Biochemistry and Cell Biology
SKE Research Equipment
State Key Laboratory of Experimental Hematology
Commission for Technology and Innovation
Swiss Federal Laboratories for Materials Science and Technology
Texas Tech University Health Sciences Center
Development Bank of Wales
Ministry of Higher Education, Research and Innovation (France)
The Idea Village
Institute for Molecular Medicine Finland
Mario Negri Institute for Pharmacological Research
University of Alberta
University of Bath
University of Brescia
University of Bristol
University of Manchester
University of Milan
University of Strathclyde
University of Zurich
Thermo Fisher Scientific
Tianjin Weikai Biological Engineering
Tokyo Future Style
Technical University of Berlin
UK Innovation & Science Seed Fund
Science and Technology Facilities Council (STFC)
UK Science and Technology Facilities Council
University of Genoa
University College London
University Hospital Zurich
University of Arkansas for Medical Sciences
University of California
University of Central Florida
University of Nottingham
The University of Sheffield
University of Washington School of Pharmacy
University of Zurich
U.S. Small Business Administration
VA Portland Health Care System
Wake Forest Institute for Regenerative Medicine
Women Who Tech
For more information about this report visit https://www.researchandmarkets.com/r/jpy37n
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-3d-cell-culture-market-report-2020-an-in-depth-analysis-of-over-8-400-patents-2015-2020---forecast-to-2030--301207661.html
SOURCE Research and Markets